Showing results (1471-1480 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|December 10, 2015
Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal ExposureLisa C Martial, Roger J M Brüggemann, Jeroen A Schouten, et al.Clinical Pharmacokinetics|November 1, 1989
Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I)P Veng-PedersenClinical Pharmacokinetics|August 10, 2017
Clinical Pharmacokinetics and Pharmacodynamics of MicafunginRoeland E Wasmann, Eline W Muilwijk, David M Burger, et al.Clinical Pharmacokinetics|August 31, 2017
Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal CancerSander Ketzer, Kirsten Schimmel, Miriam Koopman, et al.Clinical Pharmacokinetics|July 27, 2017
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic ModelingStein Schalkwijk, Aaron O Buaben, Jolien J M Freriksen, et al.Clinical Pharmacokinetics|August 2, 2017
Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy AdultsJohanna Melin, Zinnia P Parra-Guillen, Niklas Hartung, et al.Clinical Pharmacokinetics|May 20, 2016
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic AnalysisRune V Overgaard, Kristin C Petri, Lisbeth V Jacobsen, et al.Clinical Pharmacokinetics|May 23, 2016
Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent-Metabolite Population Pharmacokinetic ModelSarah F Cook, Chris Stockmann, Samira Samiee-Zafarghandy, et al.Clinical Pharmacokinetics|May 23, 2016
Blinatumomab, a Bispecific T-cell Engager (BiTE(®)) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its ImplicationsMin Zhu, Benjamin Wu, Christian Brandl, et al.Clinical Pharmacokinetics|March 1, 1989
Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepamJ M Scavone, G T Blyden, D J GreenblattPageof 348